Paolini John F. bought KNSA
October 31, 2025 · Form 4 insider transaction
Paolini John F. bought 46,000 shares of Kiniksa Pharmaceuticals International, plc at $8.83 per share, a transaction worth $406.2K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
46,000
Price
$8.83
Total value
$406.2K
InsiderPaolini John F.
RoleOfficer
SecurityClass A Ordinary Share
Transaction codeM: Option exercise
Transaction dateOctober 31, 2025
Filing dateNovember 4, 2025
Shares owned after143,866
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on July 30, 2025.